ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 4411 - 4425 of 5996 products
Cellular Biomedicine Reports Positive China CAR-T Cancer Data
$5.00
Available
Ambrx of San Diego Acquired by Fosun Pharma, WuXi PharmaTech and Others
$5.00
Available
GenorBio Enlists MabSpace to Discover mAbs
$5.00
Available
WuXi PharmaTech Announces eCommerce Research Chemicals Service
$5.00
Available
China Medical Systems In-Licenses Respiratory Distress Drug from Faron
$5.00
Available
Livzon Pharma to Form China JV with Cynvenio
$5.00
Available
MabSpace and Jiangsu Hengrui Collaborate on mAb Development
$5.00
Available
China's State Council Announces Healthcare Reform Policies
$5.00
Available
Ramsay Sime Darby Forms $135 Million JV with Chengdu Hospital Operator
$5.00
Available
Luye Pharma Completes US Trials of Anti-Psychotic
$5.00
Available
WuXi PharmaTech: Q1 Revenues up 23%; Earnings Flat
$5.00
Available
BeiGene Raises $97 Million to Develop Cancer Drug Portfolio
$5.00
Available
China's Hutchison MediPharma Receives $18 Million in Payments from Lilly
$5.00
Available
JHL Biotech Raises $45.6 Million in C Round
$5.00
Available
Harbin Gloria to Commercialize Constipation Drug in China
$5.00
Available